Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07695285
PHASE2

Lemborexant Use for Cognition Improvement in Postoperative Delirium in Elderly Patients: A Randomized Controlled Trial

Sponsor: Beijing Tiantan Hospital

View on ClinicalTrials.gov

Summary

This prospective, randomized controlled trial aims to investigate the perioperative use of lemborexant, an orexin receptor antagonist, for reducing postoperative delirium (POD) in elderly patients undergoing general anesthesia.

Key Details

Gender

All

Age Range

60 Years - Any

Study Type

INTERVENTIONAL

Enrollment

992

Start Date

2026-09-01

Completion Date

2029-12-31

Last Updated

2026-07-10

Healthy Volunteers

No

Interventions

DRUG

Lemborexant Pill

The intervention group will take Lemborexant tablets four times during the perioperative period

DRUG

Placebo tablet

The control group will take placebo tablets with the same appearance, smell and properties as the intervention group four times during the perioperative period